PAR 2.04% 25.0¢ paradigm biopharmaceuticals limited..

Sass, page-60

  1. 15 Posts.
    lightbulb Created with Sketch. 2
    few issues that come to mind:
    -CR for his insto mates at discounted share price
    -material slip ups in investor presentations (which the market had not yet been informed)
    -changes in key management personnel which were casually slipped to the market
    -quarterly targets in their control are not always met
    -taking on additional responsibility - board member of another listed (not necessarily a bad thing)

    im not saying it’s all his fault but it’s hard to not argue why there needs to be a segregation of the roles - PR can’t operate the ship and act in the shareholders best interest, that is clear
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
0.005(2.04%)
Mkt cap ! $85.80M
Open High Low Value Volume
25.0¢ 25.0¢ 25.0¢ $10.49K 41.96K

Buyers (Bids)

No. Vol. Price($)
3 61776 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 9587 4
View Market Depth
Last trade - 10.10am 12/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.